Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.

Item

http://www.wikidata.org/entity/Q41696221

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Autologous stem cell transplan ...... efractory follicular lymphoma.

@en

type

Item

label

Autologous stem cell transplan ...... efractory follicular lymphoma.

@en

prefLabel

Autologous stem cell transplan ...... efractory follicular lymphoma.

@en

P1476

Autologous stem cell transplan ...... refractory follicular lymphoma

@en

P2093

Alessandra Tucci

http://www.w3.org/2001/XMLSchema#string

Chiara Bottelli

http://www.w3.org/2001/XMLSchema#string

Chiara Rusconi

http://www.w3.org/2001/XMLSchema#string

Cristina Gabutti

http://www.w3.org/2001/XMLSchema#string

Daniela Troletti

http://www.w3.org/2001/XMLSchema#string

Emilio Paolo Alessandrino

http://www.w3.org/2001/XMLSchema#string

Enrica Morra

http://www.w3.org/2001/XMLSchema#string

Giuseppe Rossi

http://www.w3.org/2001/XMLSchema#string

Lucia Morello

http://www.w3.org/2001/XMLSchema#string

Manuel Gotti

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).

A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.

A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure.

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.

Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.

P304

230-234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.23919

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25502635

http://www.w3.org/2001/XMLSchema#string